Children News and Research

RSS

Interim results of Sanofi Pasteur's Influenza A (H1N1) 2009 Monovalent Vaccine clinical trials announced

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults 18 years through 64 years of age and over the age of 65 years.

3 Oct 2009

Researchers screen decades-old frozen infant stool samples to detect norovirus

A search through decades-old frozen infant stool samples has yielded rich dividends for scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

3 Oct 2009

News outlets continue to examine findings of recent U.N. report

News outlets continue to mine through the findings of the U.N.'s 2009 progress report on HIV and AIDS.

3 Oct 2009

Breast milk should not be stored and fed later

The levels of the components in breast milk change every 24 hours in response to the needs of the baby. A new study published in the journal Nutritional Neuroscience shows, for example, how this milk could help newborn babies to sleep.

3 Oct 2009

BMI training course launched by Anthem Blue Cross to tackle childhood obesity

In a continued effort to keep screening for childhood obesity at the forefront, Anthem Blue Cross' State Sponsored Business launched an innovative on-line Body Mass Index (BMI) training course featuring a virtual BMI wheel and web-based interactive practice sessions to help provide hands-on experience.

3 Oct 2009

$1 million grant to expand health insurance coverage to uninsured children

The Health Research and Educational Trust of New Jersey, an affiliate of the New Jersey Hospital Association, has been awarded a grant of nearly $1 million under a federal program aimed at expanding health insurance coverage to uninsured children.

3 Oct 2009

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

Baxter International Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) granted its “positive opinion” for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. This positive opinion confirms the acceptability of Baxter’s regulatory submission to obtain final marketing authorization and licensure of the product.

From Baxter International Inc. 3 Oct 2009

First U.S. patients could receive H1N1 vaccine next week

U.S. health officials announced Thursday the first batches of the H1N1 (swine flu) vaccine the government ordered will begin arriving in designated locations across the country on Tuesday and may be administered in the first patients by the end of next week, Reuters reports (Fox, 10/1).

3 Oct 2009

New study underscores lack of appropriate government action to ensure safety of vaccines

A new study in the leading scientific journal NeuroToxicology lends further credence to parents and scientists concerned about an increasingly aggressive childhood vaccine schedule and toxic vaccine components.

2 Oct 2009

sNDA for Clonicel submitted to the FDA

Addrenex Pharmaceuticals and Sciele Pharma, Inc., a Shionogi company today announced that Addrenex has submitted a supplemental New Drug Application (sNDA) to the United States Food and Drug Administration (FDA) for Clonicel (modified-release clonidine) to treat attention deficit hyperactivity disorder (ADHD).

2 Oct 2009

EPA reviews dioxin exposure study conducted by the University of Michigan

U.S. Environmental Protection Agency's Office of Research and Development has completed its review of a dioxin exposure study conducted by the University of Michigan in the Midland-Saginaw, Michigan area. EPA found the study was conducted well and provided useful, scientifically credible information. However, the study is of limited value to help EPA fully evaluate human exposure to levels of dioxin in the Tittabawassee River and Saginaw River and Bay.

1 Oct 2009

New global campaign aims to reduce child mortality

The charity Save the Children announced plans to launch a global campaign to reduce mortality among children younger than age 5, the Canadian Press reports (9/30).

1 Oct 2009

CSIRO launches wellbeing plan for kids

Written by researchers in CSIRO's Preventative Health National Research Flagship and based on extensive research, The CSIRO Wellbeing Plan for Kids reduces the guess work for parents by focusing on key lifestyle habits that will make a significant difference in achieving a healthy and active lifestyle for the whole family.

1 Oct 2009

Electronic medical records may help doctors spot or predict abuse

As the data stored in electronic medical records grow, the technology may be able to help doctors predict domestic abuse and other medical conditions, a new study in the British Medical Journal finds, Reuters reports. Patients with injuries, poisoning and alcoholism were more likely than others to report domestic abuse.

1 Oct 2009

Democrats shoot down Republican abortion amendment, others pass

Members of the Senate Finance Committee wrangled Wednesday over proposed amendments to tighten abortion restrictions to the panel's health reform bill, with Democrats ultimately defeating the effort.

1 Oct 2009

New software to detect multiple sclerosis before brain damage occurs

Researchers of the Unit for Systems Biology of the University of Jaén, led by Francisco J. Esteban, are developing a software for clinical use to detect multiple sclerosis even before the typical brain damage of this neurodegenerative disease appear. In order to do so, this scientific multidisciplinary team is calculating the fractal dimension of the brain images registered on magnetic resonance imaging.

1 Oct 2009

Addrenex submits a sNDA to the FDA for Clonicel

Sciele Pharma, Inc., a Shionogi company, and Addrenex Pharmaceuticals today announced that Addrenex has submitted a supplemental New Drug Application (sNDA) to the United States Food and Drug Administration (FDA) for Clonicel (modified-release clonidine) to treat attention deficit hyperactivity disorder (ADHD).

1 Oct 2009

The HealthWell Foundation 's panel discussion draws attention on growing crisis of the underinsured

On Tuesday, September 22, 2009, The HealthWell Foundation, one of America's largest co-payment assistance organizations, hosted a panel discussion to help draw attention to the growing crisis of the underinsured and the related challenges of reducing financial barriers to care.

1 Oct 2009

Diamyd Medical signs agreement with Inclinix to conduct global Phase III program

Diamyd Medical announces today that the company has signed an agreement with Inclinix Inc., North Carolina, for accelerated recruitment of children and adolescents recently diagnosed with type 1 diabetes in the US Phase III study of the diabetes vaccine Diamyd(R).

1 Oct 2009

Program to improve the lives of parents and children

Kids’ Turn (KT,) a San Francisco-based non-profit organization today announced results of a landmark study by Dr. Jeffrey Cookson, Department of Psychology at San Francisco State University.

1 Oct 2009